AACR Health Policy Subcommittee     

The AACR Health Policy Subcommittee develops and promotes policies and member education initiatives that will foster the closer integration of clinical practice and cancer research.

The Health Policy Subcommittee (HPS) of the Science Policy and Government Affairs Committee was created to address policy issues and member education initiatives that will foster the closer integration of, and clarify the evolving relationship between, cancer research and clinical practice.

Focus areas of the subcommittee include comparative effectiveness research (CER), health information technology (HIT), patient-reported outcomes (PROs) and patient participation in clinical research.

Subcommittee Documents

Cosigned Letters

Subcommittee Members    

Gilbert S. Omenn, MD, PhD  Chairperson
University of Michigan
Ann Arbor, MI

Amy P. Abernethy, MD, PhD 
Duke University School of Medicine
Durham, NC

Karen H. Antman, MD
Boston University School of Medicine
Boston, MA

William S. Dalton, MD, PhD
M2Gen, Personalized Medicine Institute at Moffitt Cancer Center
Tampa, FL

Mark A. Israel, MD
Dartmouth Norris Cotton Cancer Center
Lebanon, NH

Richard E. Kouri, PhD
North Carolina State University
Raleigh, NC

Thomas J. Lynch, Jr., MD
Yale Cancer Center
New Haven, CT

Peter J. Neumann, ScD
Tufts Medical Center
Boston, MA

Steven R. Patierno, PhD
Duke University Medical Center
Durham, NC

Scott D. Ramsey, MD, PhD
Fred Hutchinson Cancer Research Center
Seattle, WA

Mark E. Robson, MD
Memorial Sloan-Kettering Cancer Center
New York, NY

Deborah Schrag, MD, MPH
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA

Ellen V. Sigal, PhD
Friends of Cancer Research
Washington, DC

Sean R. Tunis, MD, MSc
Center for Medical Technology Policy (CMTP)
Baltimore, MD

AACR Staff Contact

Shimere Williams Sherwood, PhD, Associate Director of Science Policy
AACR Office of Science Policy and Government Affairs
Email or call (202) 898-6499